Growth Equity Opportunities Fund III, LLC

Related Filers (7)

Ownership (15)

SC 13D/A
Monday, 10/25/2021
Strongbridge Biopharma plc: Major Shareholders
SC 13D/A
Thursday, 3/11/2021
Aurinia Pharmaceuticals Inc.: Major Shareholders
3
Tuesday, 1/9/2018
Strongbridge Biopharma plc: Initial statement of beneficial ownership of securities
SC 13D
Monday, 1/9/2017
Aurinia Pharmaceuticals Inc.: Major Shareholders
SC 13D/A
Friday, 1/6/2017
Strongbridge Biopharma plc: Major Shareholders
SC 13D/A
Friday, 8/5/2016
INTERLEUKIN GENETICS INC: Major Shareholders
4
Tuesday, 8/2/2016
INTERLEUKIN GENETICS INC: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/18/2016
Strongbridge Biopharma plc: Major Shareholders
SC 13G
Wednesday, 2/11/2015
Aurinia Pharmaceuticals Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/3/2015
ALIMERA SCIENCES INC: Major Shareholders
SC 13D/A
Friday, 1/2/2015
INTERLEUKIN GENETICS INC: Major Shareholders
4
Monday, 12/29/2014
INTERLEUKIN GENETICS INC: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 5/24/2013
INTERLEUKIN GENETICS INC: Major Shareholders
3
Thursday, 5/23/2013
INTERLEUKIN GENETICS INC: Initial statement of beneficial ownership of securities
SC 13G
Friday, 7/27/2012
ALIMERA SCIENCES INC: Major Shareholders
Show More